DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine

被引:36
作者
Loparev, Vladimir N.
Rubtcova, Elena
Seward, Jane F.
Levin, Myron J.
Schmid, D. Scott
机构
[1] Ctr Dis Control & Prevent, Herpesvirus Grp, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
[2] Univ Colorado, Sch Med, Sect Pediat Infect Dis, Dept Pediat, Denver, CO 80202 USA
关键词
D O I
10.1086/510532
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Little is known about the pathogenic potential of individual strains in the varicella vaccine. We analyzed genomic variation among specimens obtained from vaccine recipients with postvaccination rash or herpes zoster (HZ), focusing on polymorphisms between live attenuated varicella vaccine virus and wild-type varicellazoster virus. Eleven of 18 postvaccination HZ specimens contained > 1 strain, and 7 of 18 appeared to be clonal. All 21 postvaccination rash specimens contained mixtures of vaccine strains. Four single-nucleotide polymorphisms (SNPs) consistently occurred in every isolate; all were polymorphisms in open-reading frame (ORF) 62, and 2 confer amino acid substitutions in the immediate-early protein 62. Four wild-type SNPs occurred in every isolate: one each occurred in ORF 10, ORF 21, ORF 62, and a noncoding region upstream of ORF 64. The frequencies of the remaining wild-type SNPs were variable, with the SNPs uniformly expressed (even in mixtures) in 20.5%-97.4% of isolates (mean frequency, 67.7%). No 2 clinical isolates had identical SNP profiles; as such, vaccine latency usually involves > 1 strain.
引用
收藏
页码:502 / 510
页数:9
相关论文
共 37 条
[1]   Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates [J].
Argaw, T ;
Cohen, JI ;
Klutch, M ;
Lekstrom, K ;
Yoshikawa, T ;
Asano, Y ;
Krause, PR .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) :1153-1157
[2]  
Arvin A.M., 2001, FIELDS OF VIROLOGY, V2, P2731
[3]   Epidemiology of varicella zoster virus infection in Canada and the United Kingdom [J].
Brisson, M ;
Edmunds, WJ ;
Law, B ;
Gay, NJ ;
Walld, R ;
Brownell, M ;
Roos, L ;
De Serres, G .
EPIDEMIOLOGY AND INFECTION, 2001, 127 (02) :305-314
[4]   THE EPIDEMIOLOGY OF VARICELLA AND ITS COMPLICATIONS [J].
CHOO, PW ;
DONAHUE, JG ;
MANSON, JE ;
PLATT, R .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) :706-712
[5]   Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002 [J].
Dayan, GH ;
Panero, MS ;
Debbag, R ;
Urquiza, A ;
Molina, M ;
Prieto, S ;
Perego, MD ;
Scagliotti, G ;
Galimberti, D ;
Carroli, G ;
Wolff, C ;
Schmid, DS ;
Loparev, V ;
Guris, D ;
Seward, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (12) :5698-5704
[6]  
DEMOIRA AP, 2005, EUROSURVEILLANCE, V10, P43
[7]  
*DIV EP, 2001, B OF 2001 COB VAC MO
[8]   Younger age at vaccination may increase risk of varicella vaccine failure [J].
Galil, K ;
Fair, E ;
Mountcastle, N ;
Britz, P ;
Seward, J .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (01) :102-105
[9]  
Gershon AA, 2001, ARCH VIR S, V17, P1
[10]  
Gomi Y, 2000, J MED VIROL, V61, P497, DOI 10.1002/1096-9071(200008)61:4<497::AID-JMV13>3.0.CO